The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by George, T. C.
Right arrow Articles by Bennett, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by George, T. C.
Right arrow Articles by Bennett, M.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 1999, 162: 2035-2043.
Copyright © 1999 by The American Association of Immunologists

Positive Recognition of MHC Class I Molecules by the Ly49D Receptor of Murine NK Cells1

Thaddeus C. George*, Llewellyn H. Mason{dagger}, John R. Ortaldo{dagger}, Vinay Kumar* and Michael Bennett2,*

* Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75235; and {dagger} Laboratory of Experimental Immunology, Division of Basic Sciences, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, MD 21702

Members of the murine Ly49 family of receptors have been shown to inhibit and activate NK cell function. Subsets of Ly49-expressing NK cells mediate the rejection of bone marrow cell allografts and the lysis of allogeneic lymphoblasts. In this report we have studied Ly49-mediated positive and negative signaling in an in vitro cytotoxicity assay using sorted NK cell subsets as effectors and a panel of 51Cr-labeled Con A lymphoblasts as targets in the presence or the absence of Abs to Ly49 and/or class I molecules. Our results demonstrate that the activating receptor Ly49D delivers stimulatory signals for target cell lysis upon interacting with H2-Dd, Dr, and Dsp2, but not H2b or H2k class I Ags. On the other hand, the inhibitory receptor Ly49G2 delivers negative signals for target cell lysis upon interacting with Dd, Dr, and H2k, but not H2b or Dsp2, class I Ags. Furthermore, Ly49-mediated negative signaling dominates Ly49D-mediated positive signaling. Thus, lysis of class I MHC-bearing targets by NK cells is not merely the consequence of the absence of an Ly49-mediated negative signal, but also requires positive recognition of class I molecules by certain Ly49 receptors. Activation of NK cells by nonself class I molecules was not predicted by the missing self hypothesis.




This article has been cited by other articles:


Home page
J. Immunol.Home page
E. Merck, R. B. Voyle, and H. R. MacDonald
Ly49D Engagement on T Lymphocytes Induces TCR-Independent Activation and CD8 Effector Functions That Control Tumor Growth
J. Immunol., January 1, 2009; 182(1): 183 - 192.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. K. Tripathy, P. A. Keyel, L. Yang, J. T. Pingel, T. P. Cheng, A. Schneeberger, and W. M. Yokoyama
Continuous engagement of a self-specific activation receptor induces NK cell tolerance
J. Exp. Med., August 4, 2008; 205(8): 1829 - 1841.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. C. Sun and L. L. Lanier
Tolerance of NK cells encountering their viral ligand during development
J. Exp. Med., August 4, 2008; 205(8): 1819 - 1828.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Laffont, C. Seillet, J. Ortaldo, J. D. Coudert, and J.-C. Guery
Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells
Blood, August 1, 2008; 112(3): 661 - 671.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. L. Blasius, W. Barchet, M. Cella, and M. Colonna
Development and function of murine B220+CD11c+NK1.1+ cells identify them as a subset of NK cells
J. Exp. Med., October 29, 2007; 204(11): 2561 - 2568.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Malarkannan, J. Regunathan, H. Chu, S. Kutlesa, Y. Chen, H. Zeng, R. Wen, and D. Wang
Bcl10 Plays a Divergent Role in NK Cell-Mediated Cytotoxicity and Cytokine Generation
J. Immunol., September 15, 2007; 179(6): 3752 - 3762.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. H. Chewning, C. N. Gudme, K. C. Hsu, A. Selvakumar, and B. Dupont
KIR2DS1-Positive NK Cells Mediate Alloresponse against the C2 HLA-KIR Ligand Group In Vitro
J. Immunol., July 15, 2007; 179(2): 854 - 868.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. A. Guethlein, A. M. Older Aguilar, L. Abi-Rached, and P. Parham
Evolution of Killer Cell Ig-Like Receptor (KIR) Genes: Definition of an Orangutan KIR Haplotype Reveals Expansion of Lineage III KIR Associated with the Emergence of MHC-C
J. Immunol., July 1, 2007; 179(1): 491 - 504.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. H. Johansson, M. A. Taylor, M. Jagodic, K. Tus, J. D. Schatzle, E. K. Wakeland, and M. Bennett
Mapping of Quantitative Trait Loci Determining NK Cell-Mediated Resistance to MHC Class I-Deficient Bone Marrow Grafts in Perforin-Deficient Mice
J. Immunol., December 1, 2006; 177(11): 7923 - 7929.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. R. Ortaldo, R. Winkler-Pickett, J. Wigginton, M. Horner, E. W. Bere, A. T. Mason, N. Bhat, J. Cherry, M. Sanford, D. L. Hodge, et al.
Regulation of ITAM-positive receptors: role of IL-12 and IL-18
Blood, February 15, 2006; 107(4): 1468 - 1475.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Huang, F. Rezzoug, H. Xu, P. M. Chilton, C. L. Schanie, I. Fugier-Vivier, and S. T. Ildstad
NK Cells Play a Critical Role in the Regulation of Class I-Deficient Hemopoietic Stem Cell Engraftment: Evidence for NK Tolerance Correlates with Receptor Editing
J. Immunol., September 15, 2005; 175(6): 3753 - 3761.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
N. D. Huntington, Y. Xu, S. L. Nutt, and D. M. Tarlinton
A requirement for CD45 distinguishes Ly49D-mediated cytokine and chemokine production from killing in primary natural killer cells
J. Exp. Med., May 2, 2005; 201(9): 1421 - 1433.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Naper, K.-Z. Dai, L. Kveberg, B. Rolstad, E. C. Niemi, J. T. Vaage, and J. C. Ryan
Two Structurally Related Rat Ly49 Receptors with Opposing Functions (Ly49 Stimulatory Receptor 5 and Ly49 Inhibitory Receptor 5) Recognize Nonclassical MHC Class Ib-Encoded Target Ligands
J. Immunol., March 1, 2005; 174(5): 2702 - 2711.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Regunathan, Y. Chen, D. Wang, and S. Malarkannan
NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors
Blood, January 1, 2005; 105(1): 233 - 240.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H.-C. Wang, D. Montufar-Solis, B.-B. Teng, and J. R. Klein
Maximum Immunobioactivity of Murine Small Intestinal Intraepithelial Lymphocytes Resides in a Subpopulation of CD43+ T Cells
J. Immunol., November 15, 2004; 173(10): 6294 - 6302.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. J. Lavender, B. J. Ma, E. T. Silver, and K. P. Kane
The Rat RT1-A1c MHC Molecule Is a Xenogeneic Ligand Recognized by the Mouse Activating Ly-49W and Inhibitory Ly-49G Receptors
J. Immunol., March 15, 2004; 172(6): 3518 - 3526.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Y. Koh, J. R. Ortaldo, B. R. Blazar, M. Bennett, and W. J. Murphy
NK-cell purging of leukemia: superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade
Blood, December 1, 2003; 102(12): 4067 - 4075.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. J. Ma, E. T. Silver, B. Hazes, and K. P. Kane
Reciprocal Transfer of Class I MHC Allele Specificity between Activating Ly-49P and Ly-49W Receptors by Exchange of {beta}4-{beta}5 Loop Residues
J. Immunol., November 15, 2003; 171(10): 5337 - 5344.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. H. Mason, J. Willette-Brown, S. K. Anderson, W. G. Alvord, R. L. Klabansky, H. A. Young, and J. R. Ortaldo
Receptor Glycosylation Regulates Ly-49 Binding to MHC Class I
J. Immunol., October 15, 2003; 171(8): 4235 - 4242.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Inngjerdingen, B. Rolstad, and J. C. Ryan
Activating and Inhibitory Ly49 Receptors Modulate NK Cell Chemotaxis to CXC Chemokine Ligand (CXCL) 10 and CXCL12
J. Immunol., September 15, 2003; 171(6): 2889 - 2895.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. R. Ortaldo and H. A. Young
Expression of IFN-{gamma} Upon Triggering of Activating Ly49D NK Receptors In Vitro and In Vivo: Costimulation with IL-12 or IL-18 Overrides Inhibitory Receptors
J. Immunol., February 15, 2003; 170(4): 1763 - 1769.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Raziuddin, D. L. Longo, M. Bennett, R. Winkler-Pickett, J. R. Ortaldo, and W. J. Murphy
Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens
Blood, September 26, 2002; 100(8): 3026 - 3033.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Furukawa, K. Iizuka, J. Poursine-Laurent, N. Shastri, and W. M. Yokoyama
A Ligand for the Murine NK Activation Receptor Ly-49D: Activation of Tolerized NK Cells from {beta}2-Microglobulin- Deficient Mice
J. Immunol., July 1, 2002; 169(1): 126 - 136.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Gao, T. Dang, and D. Yuan
IFN-{gamma}-Dependent and -Independent Initiation of Switch Recombination by NK Cells
J. Immunol., August 15, 2001; 167(4): 2011 - 2018.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
K. A. Daniels, G. Devora, W. C. Lai, C. L. O'Donnell, M. Bennett, and R. M. Welsh
Murine Cytomegalovirus Is Regulated by a Discrete Subset of Natural Killer Cells Reactive with Monoclonal Antibody to Ly49H
J. Exp. Med., June 25, 2001; 194(1): 29 - 44.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Fahlen, U. Lendahl, and C. L. Sentman
MHC Class I-Ly49 Interactions Shape the Ly49 Repertoire on Murine NK Cells
J. Immunol., June 1, 2001; 166(11): 6585 - 6592.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Y. Koh, B. R. Blazar, T. George, L. A. Welniak, C. M. Capitini, A. Raziuddin, W. J. Murphy, and M. Bennett
Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo
Blood, May 15, 2001; 97(10): 3132 - 3137.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
N. Matsumoto, K. Tajima, M. Mitsuki, and K. Yamamoto
H-2 allele specificity of the NK cell C-type lectin-like MHC class I receptor Ly49A visualized by soluble Ly49A tetramer
Int. Immunol., May 1, 2001; 13(5): 615 - 623.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. R. Ortaldo, E. W. Bere, D. Hodge, and H. A. Young
Activating Ly-49 NK Receptors: Central Role in Cytokine and Chemokine Production
J. Immunol., April 15, 2001; 166(8): 4994 - 4999.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. P. Makrigiannis, A. T. Pau, A. Saleh, R. Winkler-Pickett, J. R. Ortaldo, and S. K. Anderson
Class I MHC-Binding Characteristics of the 129/J Ly49 Repertoire
J. Immunol., April 15, 2001; 166(8): 5034 - 5043.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. R. Ortaldo, R. Winkler-Pickett, and G. Wiegand
Activating Ly-49D NK receptors: expression and function in relation to ontogeny and Ly-49 inhibitor receptors
J. Leukoc. Biol., November 1, 2000; 68(5): 748 - 756.
[Abstract] [Full Text]


Home page
J. Leukoc. Biol.Home page
A. P. Makrigiannis, J. Etzler, R. Winkler-Pickett, A. Mason, J. R. Ortaldo, and S. K. Anderson
Identification of the Ly49L protein: evidence for activating counterparts to inhibitory Ly49 proteins
J. Leukoc. Biol., November 1, 2000; 68(5): 765 - 771.
[Abstract] [Full Text]


Home page
J. Leukoc. Biol.Home page
L. H. Mason
Recognition of CHO cells by inhibitory and activating Ly-49 receptors
J. Leukoc. Biol., October 1, 2000; 68(4): 583 - 586.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
E. T. Silver, D.-E. Gong, C. S. Chang, A. Amrani, P. Santamaria, and K. P. Kane
Ly-49P Activates NK-Mediated Lysis by Recognizing H-2Dd 1
J. Immunol., August 15, 2000; 165(4): 1771 - 1781.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
M. C. Nakamura, S. Hayashi, E. C. Niemi, J. C. Ryan, and W. E. Seaman
Activating Ly-49D and Inhibitory Ly-49A Natural Killer Cell Receptors Demonstrate Distinct Requirements for Interaction with H2-Dd
J. Exp. Med., August 8, 2000; 192(3): 447 - 454.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Lowin-Kropf, B. Kunz, F. Beermann, and W. Held
Impaired Natural Killing of MHC Class I-Deficient Targets by NK Cells Expressing a Catalytically Inactive Form of SHP-1
J. Immunol., August 1, 2000; 165(3): 1314 - 1321.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Raziuddin, M. Bennett, R. Winkler-Pickett, J. R. Ortaldo, D. L. Longo, and W. J. Murphy
Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2b bone marrow cell allografts
Blood, June 15, 2000; 95(12): 3840 - 3844.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Liu, M. A. Morris, P. Nguyen, T. C. George, E. Koulich, W. C. Lai, J. D. Schatzle, V. Kumar, and M. Bennett
Ly49I NK Cell Receptor Transgene Inhibition of Rejection of H2b Mouse Bone Marrow Transplants
J. Immunol., February 15, 2000; 164(4): 1793 - 1799.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. H. Mason, J. Willette-Brown, A. T. Mason, D. McVicar, and J. R. Ortaldo
Interaction of Ly-49D+ NK Cells with H-2Dd Target Cells Leads to Dap-12 Phosphorylation and IFN-{gamma} Secretion
J. Immunol., January 15, 2000; 164(2): 603 - 611.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. R. Ortaldo, R. Winkler-Pickett, J. Willette-Brown, R. L. Wange, S. K. Anderson, G. J. Palumbo, L. H. Mason, and D. W. McVicar
Structure/Function Relationship of Activating Ly-49D and Inhibitory Ly-49G2 NK Receptors ,2
J. Immunol., November 15, 1999; 163(10): 5269 - 5277.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. C. Nakamura, C. Naper, E. C. Niemi, S. C. Spusta, B. Rolstad, G. W. Butcher, W. E. Seaman, and J. C. Ryan
Natural Killing of Xenogeneic Cells Mediated by the Mouse Ly-49D Receptor
J. Immunol., November 1, 1999; 163(9): 4694 - 4700.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. H. Chung, J. Dorfman, D. Plaksin, K. Natarajan, I. M. Belyakov, R. Hunziker, J. A. Berzofsky, W. M. Yokoyama, M. G. Mage, and D. H. Margulies
NK and CTL Recognition of a Single Chain H-2Dd Molecule: Distinct Sites of H-2Dd Interact with NK and TCR
J. Immunol., October 1, 1999; 163(7): 3699 - 3708.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. C. George, J. R. Ortaldo, S. Lemieux, V. Kumar, and M. Bennett
Tolerance and Alloreactivity of the Ly49D Subset of Murine NK Cells
J. Immunol., August 15, 1999; 163(4): 1859 - 1867.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. H. Idris, H. R. C. Smith, L. H. Mason, J. R. Ortaldo, A. A. Scalzo, and W. M. Yokoyama
The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killing
PNAS, May 25, 1999; 96(11): 6330 - 6335.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.